Last updated: 11/03/2018 16:56:28

Epidemiologic study to evaluate the proportion of cardiovascular disease Risk Factors in Korean hypertensive patientsWONDeR

GSK study ID
114619
See study documents
Clinicaltrials.gov ID
NCT01362283
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: A multi-center, observational, cross-sectional study to evaluate CVD risk factors in Korean hypertensive patients
Trial description: The purpose of this study is investigating the proportion of Cardiovascular disease risk factors of hypertensive patients.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:

Proportion of patients with cardiovascular disease high risk factors

Timeframe: 6years, average duration of hypertension

Secondary outcomes:

Proportion of patients with Cardiovascular disease risk factors

Timeframe: 6years, average duration of hypertension

Proportion of patients with Cardiovascular disease

Timeframe: 6years, average duration of hypertension

Target Blood Pressure achievement rate according to the proportion of Cardiovascular disease risks

Timeframe: 6years, average duration of hypertension

Interventions:
  • Other: Blood Sampling
    • Enrollment:
    3109
    Primary completion date:
    Not applicable
    Observational study model:
    Other
    Time perspective:
    Cross-Sectional
    Clinical publications:
    Not applicable
    Medical condition
    Hypertension
    Product
    Not applicable
    Collaborators
    Not applicable
    Study date(s)
    August 2010 to January 2011
    Type
    Observational
    Phase
    Not applicable

    Participation criteria

    Sex
    Female & Male
    Age
    18+ years
    Accepts healthy volunteers
    No
    • Essential hypertensive patient no less than 18 yeas old
    • Patient who gave informed consent form
    • Patient was diagnosed as secondary hypertension
    • Patient who have white-coat hypertension
    Inclusion and exclusion criteria
    Inclusion criteria:
    • Essential hypertensive patient no less than 18 yeas old
    • Patient who gave informed consent form
    Exclusion criteria:
    • Patient was diagnosed as secondary hypertension
    • Patient who have white-coat hypertension

    Trial location(s)

    This study does not involve prospective enrollment of participants.

    Study documents

    Scientific result summary
    Available language(s): English
    Download document(s)

    If you wish to request for full study report, please contact - [email protected]

    Results overview

    Refer to study documents

    Recruitment status
    Study complete
    Actual primary completion date
    Not applicable
    Actual study completion date
    2011-17-01

    Plain language summaries

    Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

    Additional information about the trial

    Not applicable
    Participate in clinical trial
    Access to clinical trial data by researchers
    Visit website